Verified peer comparison
ACADIA Pharmaceuticals Inc. - Common Stock vs Figma Financial Comparison
ACADIA Pharmaceuticals Inc. - Common Stock versus Figma using 2025 financials i…
Direct answer
ACADIA Pharmaceuticals Inc. - Common Stock and Figma are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Verified data
- ACADIA Pharmaceuticals Inc. - Common Stock Revenue
- 1,071,505,000 USD
- Figma Revenue
- 1,055,788,000 USD
- ACADIA Pharmaceuticals Inc. - Common Stock Operating income
- 104,811,000 USD
- Figma Operating income
- -1,290,457,000 USD